Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sweeney

Showing results (131-140 of 170) with videos related to

Pageof 17
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidanceW Byon, M K Smith, P Chan, et al.
The New England Journal of Medicine|December 4, 1986
Acute cardiac events temporally related to cocaine abuseJ M Isner, N A Estes, P D Thompson, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphomaD R Mould, K Sweeney, S B Duffull, et al.
Annals of Clinical Biochemistry|May 1, 1996
Vitamin E and exercise in the Northern Ireland populationE B Duly, T R Trinick, D G Kennedy, et al.
International Journal of Sports Medicine|December 5, 1998
Levels of physical activity, physical fitness and their relationship in the Northern Ireland Health and Activity SurveyD MacAuley, E E Mc Crum, G Stott, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|July 24, 2024
Spring-mediated distraction enterogenesis may alter the course of adaptation in porcine short bowel syndromeGeoanna M Bautista, Genia Dubrovsky, Nicolle K Sweeney, et al.
Acta Psychiatrica Scandinavica|April 1, 2018
Natural cause mortality in persons with serious mental illnessF Dickerson, A Origoni, J Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Finding the perfect spot for fluorine: improving potency up to 40-fold during a rational fluorine scan of a Bruton's Tyrosine Kinase (BTK) inhibitor scaffoldYan Lou, Zachary K Sweeney, Andreas Kuglstatter, et al.
Journal of Medicinal Chemistry|May 18, 2012
Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modelingHuifen Chen, Bryan K Chan, Jason Drummond, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond - Part 2Daniel G M Shore, Zachary K Sweeney, Alan Beresford, et al.
Pageof 17

Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidanceW Byon, M K Smith, P Chan, et al.
The New England Journal of Medicine|December 4, 1986
Acute cardiac events temporally related to cocaine abuseJ M Isner, N A Estes, P D Thompson, et al.
Clinical Pharmacology and Therapeutics|May 29, 2009
A population pharmacokinetic and pharmacodynamic evaluation of pralatrexate in patients with relapsed or refractory non-Hodgkin's or Hodgkin's lymphomaD R Mould, K Sweeney, S B Duffull, et al.
Annals of Clinical Biochemistry|May 1, 1996
Vitamin E and exercise in the Northern Ireland populationE B Duly, T R Trinick, D G Kennedy, et al.
International Journal of Sports Medicine|December 5, 1998
Levels of physical activity, physical fitness and their relationship in the Northern Ireland Health and Activity SurveyD MacAuley, E E Mc Crum, G Stott, et al.
Frontiers in Gastroenterology (Lausanne, Switzerland)|July 24, 2024
Spring-mediated distraction enterogenesis may alter the course of adaptation in porcine short bowel syndromeGeoanna M Bautista, Genia Dubrovsky, Nicolle K Sweeney, et al.
Acta Psychiatrica Scandinavica|April 1, 2018
Natural cause mortality in persons with serious mental illnessF Dickerson, A Origoni, J Schroeder, et al.
Bioorganic & Medicinal Chemistry Letters|December 4, 2014
Finding the perfect spot for fluorine: improving potency up to 40-fold during a rational fluorine scan of a Bruton's Tyrosine Kinase (BTK) inhibitor scaffoldYan Lou, Zachary K Sweeney, Andreas Kuglstatter, et al.
Journal of Medicinal Chemistry|May 18, 2012
Discovery of selective LRRK2 inhibitors guided by computational analysis and molecular modelingHuifen Chen, Bryan K Chan, Jason Drummond, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2018
Discovery of potent azaindazole leucine-rich repeat kinase 2 (LRRK2) inhibitors possessing a key intramolecular hydrogen bond - Part 2Daniel G M Shore, Zachary K Sweeney, Alan Beresford, et al.
Pageof 17